Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Once-Daily for BPH in Asian Men
NCT01460342Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tadalafil in benign prostatic hyperplasia (BPH), sponsored by Eli Lilly and Company. Started Dec 2011; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01460342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460342.